Evocalcet

Evocalcet
Clinical data
Trade names	Orkedia
ATC code	H05BX06 (WHO) ;
Identifiers
	IUPAC name 2-[4-[(3S)-3-[[(1R)-1-Naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]acetic acid;
CAS Number	870964-67-3;
PubChem CID	71242808;
DrugBank	DB12388;
UNII	E58MLH082P;
KEGG	D11063;
CompTox Dashboard (EPA)	DTXSID101132784 ;
Chemical and physical data
Formula	C24H26N2O2
Molar mass	374.484 g·mol−1

Evocalcet (trade name Orkedia) is a drug for the treatment of hyperparathyroidism.^[1] It acts as a calcium-sensing receptor agonist.^[2]

Quick Facts Clinical data, Trade names ...

In 2018, it was approved in Japan for treatment of secondary hyperparathyroidism in patients on dialysis.^[3]

References